Philips

Philips welcomes you to SLICE online 2020!

 

When it comes to acute stroke, everyone deserves the best care.

Today, more patients can benefit from mechanical thrombectomy through changed guidelines, which widen the time window for endovascular treatment1.  Find out why the Direct To Angio Suite (DTAS) is an effective approach to optimize workflow and reduce time

Learn more about Direct To Angio workflow

Be ready to take on new challenges in ischemic stroke treatment

Philips Neuro suite offers a flexible portfolio of integrated technologies, services, and neuro accessories that puts you in firm control. You can work with the confidence that comes from using sophisticated imaging technologies and neuro options that are the result of intensive research with clinical leaders and industry pioneers in neuro interventions.

We see a strong increase in thrombectomy interventions as a first line treatment for patients with ischemic stroke. There is also a shift from time-based to image-based patient selection for ischemic stroke treatment. Our Neuro suite has been developed to address these trends. It can support high levels of procedural efficiency and redefine outcomes for your stroke patients.

More about Neurosuite

Visit our symposia

  • Raul Nogueira (Atlanta) and Dr. Marc Ribo (Barcelona) will explain their perspective in the Direct To Angio Suite vision and – for the first time – present on the outline of the WE-TRUST study.
  • Another first; Dr. Vincent Costalat (Montpellier) will share his first experiences with SmartCT2during stroke diagnosis in the Azurion neuro suite.

 

 

1 Mokin M, Ansari SA, McTaggart RA, Society of NeuroInterventional Surgery, et al. Indications for thrombectomy in acute ischemic stroke from emergent large vessel occlusion (ELVO): report of the SNIS Standards and Guidelines Committee, Journal of NeuroInterventional Surgery 2019;11:215-220.

2SmartCT is 510k pending in the USA. Not available for sale in the U.S.A.